A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2, randomized, multicenter, parallel group, double-blind, dose-ranging,
placebo-controlled evaluation of the analgesic efficacy, safety and pharmacokinetics of
ketamine sublingual wafer in adult subjects who experience post operative pain after
undergoing third molar extraction.